herb
plantago
asiatica
clerodendrum
trichotomum
commonli
use
centuri
indigen
folk
medicin
tropic
subtrop
region
world
studi
show
extract
herb
antivir
effect
respiratori
syncyti
viru
rsv
vitro
cell
cultur
vivo
mous
model
treatment
cell
cell
noncytotox
concentr
plantago
asiatica
clerodendrum
trichotomum
extract
significantli
reduc
rsv
replic
rsvinduc
cell
death
rsv
gene
transcript
rsv
protein
synthesi
also
block
syncytia
format
interestingli
oral
inocul
herb
extract
significantli
improv
viral
clearanc
lung
balbc
mice
base
report
inform
highperform
liquid
chromatographi
hplc
analysi
phenol
glycosid
acteosid
identifi
activ
chemic
compon
herb
extract
effect
dose
acteosid
exhibit
similar
antivir
effect
herb
extract
rsv
vitro
vivo
collect
result
suggest
extract
plantago
asiatica
clerodendrum
trichotomum
could
provid
potent
natur
sourc
antivir
drug
candid
rsv
infect
acut
respiratori
infect
caus
virus
common
caus
morbid
mortal
children
worldwid
respiratori
syncyti
viru
rsv
one
major
caus
lower
respiratori
tract
infect
caus
huge
global
diseas
burden
import
viral
agent
seriou
respiratori
tract
ill
infant
young
children
nearli
infant
infect
rsv
least
age
two
year
rsv
also
major
caus
acut
respiratori
ill
elderli
detriment
effect
immunecompromis
individu
even
though
rsv
infect
gener
occur
earli
age
individu
may
reinfect
throughout
lifetim
natur
acquir
immun
provid
persist
protect
present
rsv
vaccin
antivir
drug
preclin
clinic
stage
develop
howev
rsv
vaccin
antivir
drug
suitabl
typic
use
commerci
avail
time
ribavirin
immunoglobulin
prepar
high
titer
rsvspecif
neutral
antibodi
current
approv
treat
prevent
rsv
infect
howev
neither
option
costeffect
conveni
administ
due
high
infant
morbid
mortal
rate
lack
effect
vaccin
avail
one
antivir
agent
ribavirin
use
sever
case
novel
therapi
rsv
infect
warrant
investig
fossil
evid
reveal
human
use
plant
folk
medicin
date
back
least
year
accord
world
health
organ
almost
world
popul
report
use
natur
compound
medicin
agent
modern
analyt
technolog
appli
toward
activ
compound
found
plant
allow
greater
insight
plantderiv
pharmaceut
compound
plantago
asiatica
perenni
belong
famili
plantaginacea
commonli
use
folk
medicin
korea
china
japan
plantago
asiatica
extract
pae
use
treat
varieti
health
condit
wound
cholesterolemia
diarrhea
bronchiti
chronic
constip
moreov
shown
inhibit
cancer
leukemia
growth
enhanc
cellmedi
immun
clerodendrum
trichotomum
decidu
shrub
belong
famili
lamiacea
formerli
verbenacea
wide
distribut
south
korea
china
japan
philippin
clerodendrum
trichotomum
extract
cte
possess
broadspectrum
antiinflammatori
antihypertens
antiasthmat
antioxid
immunotoxin
properti
howev
effect
pae
cte
activ
compon
rsv
replic
vitro
vivo
report
studi
evalu
antivir
activ
p
asiatica
c
trichotomum
aqueou
extract
rsv
vitro
vivo
furthermor
identifi
confirm
antivir
function
acteosid
verbascosid
phenol
glycosid
present
aqueou
extract
potenti
activ
compon
antivir
activ
rsv
infect
watersolubl
extract
p
asiatica
c
trichotomum
prepar
herbal
medicin
improv
research
center
korea
institut
orient
medicin
daejeon
republ
korea
crude
plant
materi
purchas
local
store
jaecheon
orient
herbal
market
verifi
professor
kihwan
bae
colleg
pharmaci
chungnam
nation
univers
prose
g
plant
materi
place
l
distil
water
extract
heat
h
c
use
medic
heat
plate
extract
prose
extract
subject
filtrat
use
filter
paper
millex
darmstadt
germani
store
c
h
extract
centrifug
g
min
supernat
collect
ph
adjust
follow
ph
adjust
total
success
aqueou
extract
subject
membran
syring
filtrat
store
c
use
verbascosid
acteosid
purchas
sigma
trypan
blue
solut
purchas
gibco
waltham
usa
cell
cytotox
assay
kit
purchas
dojindo
molecular
technolog
inc
cell
count
japan
antibodi
use
immunoblot
studi
follow
antirsv
glycoprotein
rsvg
abcam
cambridg
uk
santa
cruz
sc
dalla
tx
usa
hrpconjug
antimous
igg
gene
tex
taichung
taiwan
hrpconjug
antirabbit
igg
cell
signal
technolog
danver
usa
human
epitheli
type
cell
hela
contamin
atcc
manassa
va
usa
cell
atcc
manassa
va
usa
maintain
dulbecco
modifi
eagl
medium
dmem
invitrogen
waltham
usa
supplement
fetal
bovin
serum
fb
hyclon
australia
antibioticantimycot
solut
gibco
waltham
usa
c
co
environ
green
fluoresc
protein
fuse
respiratori
syncyti
viru
rsvgfp
dr
jae
u
jung
depart
molecular
microbiolog
immunolog
univers
southern
california
usa
rsvgfp
propag
confluent
cell
titer
determin
standard
plaqu
assay
rsvgfp
viru
replic
inhibit
assay
perform
vitro
use
cell
describ
previous
minor
modif
briefli
cell
cell
seed
well
cell
cultur
plate
cell
number
cellswel
incub
h
medium
chang
dmem
contain
fb
cell
infect
rsvgfp
multipl
infect
moi
h
cell
wash
pb
medium
replac
dmem
contain
fb
cell
treat
indic
concentr
pae
cte
acteosid
gfp
express
measur
h
post
infect
hpi
glomax
multidetect
system
follow
manufactur
direct
viru
titer
determin
supernat
cell
plaqu
assay
cell
cell
cell
viabil
evalu
use
trypan
blue
exclus
test
describ
previous
cell
grown
cell
cultur
plate
cellswel
incub
c
co
atmospher
h
medium
replac
dmem
contain
fb
cell
infect
rsvgfp
moi
h
cell
wash
pb
medium
replac
dmem
contain
fb
cell
treat
indic
concentr
herb
extract
acteosid
experi
perform
triplic
gfp
express
measur
hpi
glomax
multidetect
system
promega
fitchburg
wi
usa
accord
manufactur
instruct
ec
valu
calcul
extract
concentr
yield
gfp
express
cell
cytotox
concentr
herb
extract
acteosid
determin
use
cell
count
dojindo
molecular
technolog
describ
previous
briefli
cell
seed
cell
cultur
plate
cellswel
incub
h
cell
treat
indic
concentr
herb
extract
acteosid
next
post
treatment
solut
ad
well
plate
incub
h
c
absorb
measur
nm
use
micropl
reader
molecular
devic
total
rna
extract
cell
g
lung
homogen
use
rneasi
mini
kit
qiagen
hiden
germani
cdna
synthesi
perform
use
enzym
revers
transcriptas
toyobo
next
qrtpcr
perform
use
rotor
gene
q
instrument
qiagen
hiden
germani
quantitect
sybr
green
pcr
master
mix
qiagen
hiden
germani
transcript
level
mrna
obtain
method
describ
previous
express
fold
induct
rtpcr
primer
sequenc
use
follow
rsvg
forward
primer
revers
primer
glyceraldehyd
dehydrogenas
gapdh
forward
primer
revers
primer
cell
seed
six
well
cell
cultur
plate
cellswel
incub
h
medium
chang
dmem
contain
fb
cell
infect
rsvgfp
moi
h
cell
treat
pae
cte
acteosid
replac
medium
dmem
contain
fb
cell
harvest
hpi
subject
immunoblot
analysi
briefli
harvest
cell
lyse
lysi
buffer
contain
mm
nacl
mm
trishcl
ph
proteas
inhibitor
sigma
whole
cell
lysat
mix
sampl
buffer
sigma
st
loui
mo
usa
ratio
total
protein
separ
gel
sdspage
transfer
pvdf
membran
biorad
hercul
ca
usa
membran
block
bovin
serum
albumin
bsa
sigma
incub
anti
rsvg
antibodi
antibodi
bsa
tbst
trisbuff
salin
lp
solut
tween
life
scienc
suwane
ga
usa
respect
protein
detect
incub
secondari
antirabbit
igghrp
antimous
igghrp
h
room
temperatur
membran
develop
ecl
reagent
mix
lp
solut
imag
captur
enhanc
chemiluminesc
detect
ecl
system
ge
life
scienc
pittsburgh
pa
usa
use
mini
luminoimag
analyz
ge
life
scienc
band
intens
calcul
use
imagequ
la
control
softwar
pittsburgh
pa
usa
abil
herb
extract
acteosid
block
cell
cell
spread
evalu
use
gfp
express
cell
cell
cultur
well
cell
cultur
plate
cellswel
incub
h
medium
chang
dmem
contain
fb
cell
infect
rsvgfp
moi
h
cell
treat
paect
acteosid
replac
medium
dmem
contain
fb
h
incub
cell
wash
cool
pb
cell
imag
taken
magnif
syncytium
format
quantifi
imagej
program
http
imagejnetimagej
fiveweekold
femal
balbc
mice
purchas
orient
bio
south
korea
acclim
three
day
experiment
condit
prior
use
mice
separ
experiment
group
viru
infect
herb
acteosid
treat
group
n
viru
infect
group
n
un
infect
group
n
mice
anesthet
ketamin
short
time
period
rsvgfp
plaqu
form
unit
pfu
per
mice
total
volum
infect
intranas
mice
oral
administ
mgml
concentr
pae
cte
total
volum
hpi
case
acteosid
mgkg
bodi
weightmic
intraperitoni
administ
mice
hpi
total
volum
lung
tissu
euthan
mice
collect
asept
post
infect
dpi
lung
rsv
titrat
determin
rsvg
protein
mrna
transcript
fold
quantif
rsvg
protein
mrna
level
quantifi
describ
anim
studi
conduct
appropri
condit
approv
institut
anim
care
use
committe
chungnam
nation
univers
refer
number
reversedphas
highperform
liquid
chromatographi
hplc
perform
use
agil
technolog
seri
hplc
system
equip
dad
detector
agil
technolog
santa
clara
ca
usa
binari
mobil
phase
consist
water
contain
formic
acid
solvent
acetonitril
solvent
b
solvent
filter
filter
prior
use
mobil
phase
consist
formic
acid
solvent
acetonitril
solvent
b
gradient
mode
follow
min
b
min
b
min
b
flow
rate
mlmin
c
data
present
mean
standard
deviat
sd
repres
least
three
independ
experi
graph
statist
analysi
perform
use
graphpad
prism
softwar
version
san
diego
ca
usa
window
differ
untreat
herb
acteosid
treat
group
analyz
unpair
ttest
p
p
p
regard
signific
librari
herb
extract
screen
detect
antivir
activ
rsv
among
pae
cte
select
abil
two
herb
extract
inhibit
replic
gfptag
rsv
rsvgfp
confirm
dosedepend
experi
express
rsvgfp
viru
titer
recoveri
rsvinduc
cell
death
evalu
cell
upon
herb
treatment
shown
figur
b
cell
cell
treat
pae
cte
exhibit
mark
reduct
gfp
express
compar
untreat
cell
cell
moreov
dose
twoherb
extract
significantli
reduc
rsv
titer
compar
untreat
group
figur
interestingli
treatment
pae
cte
significantli
reduc
rsvinduc
cell
cell
death
hpi
figur
therefor
herb
extract
could
significantli
reduc
rsv
replic
cell
cell
sinc
concentr
effect
inhibit
viral
replic
virusinduc
cytotox
concentr
use
vitro
experi
abil
pae
cte
inhibit
viru
replic
infect
determin
cell
infect
rsvgfp
moi
herb
extract
ad
indic
time
point
gfp
express
measur
hpi
expect
increas
gfp
express
hpi
observ
amount
time
viral
infect
herb
treatment
increas
figur
b
similarli
rsv
titer
increas
increas
time
viral
infect
herb
extract
treatment
figur
next
assess
effect
pae
cte
viru
replic
assay
perform
gfp
express
measur
differ
time
viru
infect
shown
figur
f
concentr
herb
extract
significantli
reduc
gfp
express
hpi
hpi
interestingli
hpi
hpi
next
synergist
antirsv
effect
pae
cte
determin
cell
cell
infect
rsvgfp
h
dmem
contain
fb
cell
treat
pae
cte
along
combin
dmem
contain
fb
hpi
gfp
absorb
taken
viru
titer
determin
standard
plaqu
assay
gfp
express
level
significantli
reduc
increas
dose
either
pae
cte
along
combin
treatment
figur
howev
signific
differ
observ
combin
herb
extract
treatment
compar
individu
herb
extract
treatment
final
dose
treatment
furthermor
similar
result
observ
viru
replic
quantif
standard
plaqu
assay
figur
therefor
data
demonstr
pae
cte
enhanc
antirsv
activ
synergist
ec
valu
herb
extract
determin
rsv
cell
experi
gfp
assay
perform
modif
describ
previous
briefli
rsvgfp
viru
use
reduct
gfp
express
consid
equival
reduct
viru
titer
shown
figur
f
pae
cte
inhibit
rsvgfp
infect
moi
concentr
respect
next
determin
cc
valu
two
extract
base
cell
cytotox
assay
use
cell
assay
show
cc
valu
pae
cte
respect
figur
g
interestingli
cell
viabil
effect
concentr
extract
greater
select
index
si
indic
safeti
crude
extract
rsv
infect
si
pae
cte
respect
figur
data
suggest
pae
cte
could
use
safe
therapeut
agent
rsv
infect
calcul
ec
valu
reduct
gfp
express
consid
equival
reduct
viru
titer
ratio
cc
ec
consid
select
index
si
gfp
absorb
cell
viabil
express
mean
sd
error
bar
indic
rang
valu
obtain
count
duplic
three
independ
experi
p
p
regard
signific
differ
inhibit
intracellular
viral
rna
transcript
protein
translat
herb
extract
treatment
evalu
cell
cell
infect
rsvgfp
treat
pae
cte
hpi
cell
harvest
indic
time
point
viral
gene
express
rna
protein
level
determin
qrtpcr
immunoblot
analysi
respect
interestingli
pae
treatment
reduc
transcript
rsvg
mrna
level
hpi
hpi
similarli
cte
treatment
reduc
transcript
rsvg
mrna
level
hpi
hpi
figur
furthermor
reduct
viral
gene
transcript
cell
treat
herb
extract
associ
reduc
rsvg
protein
synthesi
figur
c
thu
reduct
viral
gene
transcript
protein
synthesi
pae
cte
correl
antivir
activ
vitro
figur
c
syncytium
format
rsv
wellknown
mechan
celltocel
infect
contribut
significantli
viru
spread
vivo
therefor
determin
whether
pae
cte
prevent
celltocel
spread
viru
infect
syncytium
format
assay
perform
infect
cell
monolay
cell
infect
rsvgfp
incub
c
h
cell
left
untreat
treat
pae
cte
examin
syncytium
format
interestingli
untreat
cell
larg
area
syncytium
format
visibl
contrast
pae
cte
treat
cell
show
significantli
reduc
syncytium
format
hpi
figur
next
design
mous
model
evalu
therapeut
effect
pae
cte
rsv
infect
vivo
balbc
mice
intranas
infect
rsvgfp
pfumous
left
uninfect
pb
pae
cte
oral
administr
hpi
rsv
infect
titer
pfumous
inocul
time
hpi
inocul
dose
mgml
micetim
chosen
base
preliminari
studi
lung
collect
asept
dpi
dpi
rsvg
protein
mrna
level
lung
determin
qrtpcr
shown
figur
paetreat
mice
show
significantli
reduc
viral
mrna
respiratori
tract
dpi
dpi
compar
control
pb
treat
group
similarli
transcript
rsvg
mrna
reduc
ctetreat
group
compar
pbstreat
group
dpi
dpi
significantli
reduc
dpi
figur
data
demonstr
herb
extract
abil
inhibit
viral
replic
mous
respiratori
tract
protect
rsv
infect
vivo
previous
report
acteosid
import
phenol
glycosid
pae
cte
investig
presenc
glycosid
pae
cte
perform
reversephas
highperform
liquid
chromatographi
hplc
extract
pae
cte
interestingli
found
extract
contain
acteosid
one
major
activ
compon
figur
assess
antivir
effect
acteosid
monolay
cell
infect
rsvgfp
hpi
cell
treat
ngml
acteosid
viru
replic
monitor
report
figur
acteosid
treatment
significantli
reduc
gfp
express
compar
untreat
cell
furthermor
viru
titer
determin
plaqu
format
assay
similar
result
gfp
express
analysi
acteosid
significantli
reduc
rsv
plaqu
titer
figur
cell
death
induc
rsv
infect
also
reduc
acteosidetr
cell
compar
untreat
cell
figur
next
ec
cc
acteosid
determin
cell
ngml
ngml
respect
figur
h
si
acteosid
rsvgfp
figur
base
data
reduc
viral
replic
caus
actiosid
figur
f
due
antivir
properti
cytotox
moreov
mrna
protein
express
viral
gene
cell
treat
acteosid
determin
herb
extract
interestingli
acteosidetr
cell
show
significantli
reduc
rsvg
mrna
compar
untreat
cell
reduct
hpi
reduct
hpi
figur
similarli
rsvg
protein
synthesi
inhibit
acteosid
treatment
figur
therefor
result
demonstr
acteosid
inhibit
rsv
replic
cell
evalu
therapeut
effect
acteosid
rsv
investig
antivir
activ
balbc
mice
mice
intranas
infect
rsvgfp
pfumous
acteosid
administr
intraperiton
hpi
dose
mgkg
describ
previous
lung
mice
collect
dpi
dpi
rsvg
mrna
measur
qrtpcr
shown
figur
level
viral
mrna
significantli
lower
acteosidetr
group
pb
control
group
dpi
dpi
taken
togeth
acteosid
exhibit
strong
vivo
antivir
effect
protect
mice
rsv
infect
tradit
medicin
use
remedi
infecti
diseas
thousand
year
due
signific
antiinflammatori
antimicrobi
activ
low
rate
advers
effect
medicin
gain
popular
due
concern
relat
side
effect
high
cost
lack
efficaci
convent
western
medicin
year
approxim
onequart
bestsel
drug
worldwid
natur
product
deriv
natur
product
recent
public
show
tradit
chines
medicin
herb
account
prescript
drug
china
perceiv
harmless
natur
wide
use
mani
part
world
individu
combin
particular
medicin
plant
shown
potenti
therapeut
effect
wide
rang
respiratori
tractrel
viral
infect
includ
sever
acut
respiratori
syndrom
sar
influenza
rsv
among
thousand
promis
medicin
herb
plantago
asiatica
clerodendrum
trichotomum
wellknown
commonli
use
tradit
medicin
china
japan
south
korea
present
studi
screen
librari
herb
extract
identifi
novel
therapeut
inhibitor
rsv
infect
interestingli
identifi
plantago
asiatica
extract
pae
clerodendrum
trichotomum
extract
cte
hit
potent
antivir
effect
rsv
infect
cell
supplementari
figur
next
confirm
dosedepend
antirsv
activ
herb
cell
line
detail
figur
addit
cc
valu
pae
cte
sever
magnitud
higher
ec
valu
figur
consist
favor
safeti
profil
furthermor
herb
extract
reduc
intracellular
viral
gene
transcript
protein
synthesi
vitro
oral
administr
herb
infect
mice
significantli
reduc
viral
gene
transcript
lung
figur
final
found
acteosid
common
phenol
glycosid
present
herb
extract
involv
antivir
activ
herb
rsv
infect
figur
pae
cte
significantli
reduc
rsv
replic
rsvmediat
syncyti
format
cell
line
dosedepend
manner
figur
moreov
curiou
evalu
whether
pae
cte
work
synergist
enhanc
antirsv
activ
howev
herb
extract
show
synergist
antirsv
effect
compar
individu
treatment
dose
figur
b
sinc
extract
reduc
viru
replic
level
treat
alon
togeth
dose
ex
pae
cte
pae
cte
possibl
herb
extract
undergo
mechan
action
antirsv
function
work
synergist
howev
pae
cte
show
cytotox
effect
cell
line
figur
g
cc
valu
pae
cte
respect
sever
magnitud
higher
ec
valu
respect
even
though
extract
use
concentr
vitro
experi
high
si
indic
broad
safeti
margin
therapeut
purpos
support
observ
mention
investig
intracellular
rsv
gene
transcript
infect
epitheli
cell
interestingli
pae
ctetreat
cell
show
significantli
reduc
rsvg
mrna
hpi
figur
reduct
viral
mrna
transcript
posit
correl
low
level
viral
replic
observ
time
point
figur
b
furthermor
paeand
ctetreat
cell
show
significantli
reduc
rsvg
protein
synthesi
late
time
point
viru
infect
figur
c
therefor
possibl
pae
cte
may
affect
replic
rsv
transcript
level
also
posttranscript
level
syncytium
format
rsv
wellknown
mechan
celltocel
infect
contribut
significantli
viru
spread
vivo
pae
cte
also
significantli
reduc
rsvdepend
format
syncytia
cell
figur
sinc
herb
extract
could
inhibit
rsv
replic
vitro
went
test
antivir
potenti
vivo
vivo
replic
rsv
also
accur
assess
qrtpcr
interestingli
vivo
result
figur
f
reveal
oral
administr
pae
cte
significantli
reduc
amount
rsvg
transcript
lung
dpi
vivo
result
consist
low
viru
titer
observ
cell
treat
pae
cte
vitro
even
though
exact
underl
therapeut
antirsv
mechan
pae
cte
still
investig
result
vitro
vitro
antivir
assay
show
herb
extract
significantli
abolish
cell
cell
viru
infect
rsv
ultim
inhibit
viru
spread
infect
site
phenylethanoid
glycosid
wide
found
edibl
plant
foodstuff
deriv
plant
compound
numer
biolog
properti
includ
antihepatotox
antiinflammatori
antinocicept
antioxid
effect
phenylethanoid
glycosid
one
major
bioactiv
constitu
present
plantago
asiatica
clerodendrum
trichotomum
hplc
analysi
conduct
confirm
find
figur
acteosid
identifi
one
major
constitu
pae
cte
acteosid
also
call
kusagin
verbascosid
phenylethanoid
glycosid
isol
mani
dicotyledon
reportedli
acteosid
antioxid
antiinflammatori
properti
prevent
cell
apoptosi
recent
studi
demonstr
acteosid
induc
erk
activ
subsequ
product
thu
show
antivir
activ
influenza
vesicular
stomat
viru
vsv
base
report
find
evalu
antivir
effect
acteosid
rsv
interestingli
acteosid
reduc
rsv
replic
virusinduc
cell
death
cell
figur
f
similar
pae
cte
treatment
addit
si
acteosid
rsv
vitro
indic
high
safeti
margin
therapeut
effect
figur
also
confirm
acteosid
reduc
level
rsvg
mrna
rsvg
protein
synthesi
hpi
figur
specif
intraperiton
treatment
acteosid
show
antirsv
effect
mous
model
figur
result
similar
antivir
activ
acteosid
influenza
vsv
howev
studi
demonstr
detail
mechan
acteosid
inhibit
rsv
replic
need
conclus
favor
safeti
profil
antivir
activ
pae
cte
acteosid
suggest
herb
extract
may
good
candid
antivir
therapi
rsv
infect
thu
oral
administr
plantago
asiatica
clerodendrum
trichotomum
administr
acteosid
could
potenti
therapeut
applic
human
livestock
supplementari
materi
follow
avail
onlin
http
figur
herb
extract
librari
screen
result
figur
select
herb
extract
second
round
screen
result
